Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Affimed N.V. - Common Stock (NQ:AFMD)

0.1815 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Affimed N.V. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting
From Affimed N.V.
Via GlobeNewswire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
Via Benzinga
Why Shares of Affimed Fell Thursday
The clinical-stage biotech focuses on immuno-oncology therapies. 
Via The Motley Fool
Recap: Affimed Q2 Earnings
  Affimed (NASDAQ:AFMD) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Affimed: Q1 Earnings Insights
Affimed (NASDAQ:AFMD) reported its Q1 earnings results on Wednesday, June 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress
From Affimed N.V.
Via GlobeNewswire
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting
From Affimed N.V.
Via GlobeNewswire
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. 
Via Benzinga
Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on November 15, 2022
From Affimed N.V.
Via GlobeNewswire
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
From Affimed N.V.
Via GlobeNewswire
Affimed to Present at the 2022 Jefferies London Healthcare Conference
From Affimed N.V.
Via GlobeNewswire
Why Affimed Stock Plummeted by Over 16% Today
An analyst's downgrade brings out the bears for the European cancer treatment developer. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
Upgrades 
Via Benzinga
Domino's Pizza To $375? Plus Stifel Cuts Price Target On This Stock By Around 78%
Credit Suisse cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $425 to $375. Domino's shares fell 0.3% to $313.70 in pre-market trading. 
Via Benzinga
Affimed Announces Two Clinical Update Presentations on its Novel Bispecific Innate Cell Engager AFM24 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
From Affimed N.V.
Via GlobeNewswire
Preview: Affimed's Earnings
  Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that Affimed will... 
Via Benzinga
7 Undervalued Biotech Stocks to Buy Before They Boom
Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy. 
Via InvestorPlace
6 Blue-Chip Stocks to Sell Now
This article is about 6 blue-chip stocks to sell now. They are severely overvalued or are likely to move down soon with a recession. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For June 1, 2022
Companies Reporting Before The Bell • Affimed (NASDAQ:AFMD) is projected to report quarterly loss at $0.19 per share on revenue of $10.05 million. 
Via Benzinga
Earnings Preview: Affimed
Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Wednesday, 2022-06-01. Here's what investors need to know before the announcement. Analysts estimate that Affimed will... 
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.